Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ: AMPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AMPH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.09B
- P/E (TTM)
- 15.11
- Forward P/E
- 8.03
- EPS (TTM)
- $1.69
- Dividend yield
- None
- 52-week range
- 16.65 – 29.52
- Day range
- 25.29 – 26.17
- Volume / Avg
- 774.80K / 467.34K
- Beta
- —
- Shares outstanding
- 42.54M
- Next earnings
- Nov 5, 2026
52-week range
AMPH stock today
On Oct 7, AMPH ended the session at $25.54, shedding $0.37 (1.43%), versus the S&P 500's 0.22% decline. At this level, AMPH sits in the middle of its 52-week range of $16.65 to $29.52: 13.5% below the high, set on Jan 12, 2026 and 53.4% above the low. AMPH is down 4.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 1.1%.
Amphastar Pharmaceuticals trades at 15.1x its trailing twelve-month earnings per share of $1.69. Its forward P/E of 8.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Amphastar Pharmaceuticals's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Amphastar Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2014
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.84
Amphastar Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LBRXLB Pharmaceuticals Inc | 34.16 | -0.29% | $1.10B | vs AMPH |
| JANXJanux Therapeutics Inc. | 17.92 | +6.73% | $1.10B | vs AMPH |
| MNKDMannKind Corporation | 3.45 | -7.01% | $1.11B | vs AMPH |
| TRAXFirst Tracks Biotherapeutics Inc. | 30.59 | -2.55% | $1.09B | vs AMPH |
| BCAXBicara Therapeutics Inc. | 16.42 | -0.85% | $1.09B | vs AMPH |
| AVLNAvalyn Pharma Inc. | 25.53 | +0.39% | $1.13B | vs AMPH |
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs AMPH |
| OPKOPKO Health Inc. | 1.39 | -4.79% | $1.04B | vs AMPH |
Indexes, lists and sector
Amphastar Pharmaceuticals stock FAQ
What is Amphastar Pharmaceuticals's stock price today?
AMPH last traded at $25.54 as of Oct 7, 4:00 PM EDT, down 1.43% on the day. Prices are delayed at least 15 minutes.
When is Amphastar Pharmaceuticals's next earnings date?
Amphastar Pharmaceuticals is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.84.
What is AMPH's P/E ratio?
AMPH trades at a trailing P/E ratio of 15.11 and a forward P/E of 8.03.
What is the AMPH 52-week high?
The 52-week high for AMPH is $29.52 and the 52-week low is $16.65. The stock is currently 13.5% below its high.